Tabula Rasa HealthCare Inc (TRHC) Downgraded to “Sell” at Zacks Investment Research

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Saturday.

According to Zacks, “Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company’s cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. “

A number of other brokerages also recently commented on TRHC. Stifel Nicolaus lifted their price objective on Tabula Rasa HealthCare from $17.00 to $19.00 and gave the stock a “buy” rating in a research report on Tuesday, March 14th. Robert W. Baird set a $17.00 price objective on Tabula Rasa HealthCare and gave the stock a “buy” rating in a research report on Thursday, January 19th. Finally, Piper Jaffray Companies lifted their price objective on Tabula Rasa HealthCare from $18.00 to $19.00 and gave the stock an “overweight” rating in a research report on Tuesday, March 14th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $17.50.

Shares of Tabula Rasa HealthCare (NASDAQ:TRHC) traded down 3.48% during midday trading on Friday, hitting $13.02. 52,199 shares of the stock were exchanged. The stock’s market cap is $222.29 million. Tabula Rasa HealthCare has a 52-week low of $10.39 and a 52-week high of $16.85. The firm’s 50 day moving average price is $13.38 and its 200-day moving average price is $13.54.

Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its quarterly earnings data on Monday, March 13th. The company reported $0.10 EPS for the quarter, missing the Zacks’ consensus estimate of $0.11 by $0.01. The company earned $27.30 million during the quarter, compared to analysts’ expectations of $25.53 million. The company’s quarterly revenue was up 37.9% on a year-over-year basis. On average, equities research analysts expect that Tabula Rasa HealthCare will post $0.41 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Tabula Rasa HealthCare Inc (TRHC) Downgraded to “Sell” at Zacks Investment Research” was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at https://www.com-unik.info/2017/04/21/zacks-investment-research-lowers-tabula-rasa-healthcare-inc-trhc-to-sell-updated-updated.html.

A number of large investors have recently bought and sold shares of TRHC. Sio Capital Management LLC acquired a new stake in Tabula Rasa HealthCare during the third quarter worth approximately $7,303,000. Cortina Asset Management LLC increased its stake in Tabula Rasa HealthCare by 16.9% in the fourth quarter. Cortina Asset Management LLC now owns 440,685 shares of the company’s stock worth $6,601,000 after buying an additional 63,627 shares in the last quarter. Monashee Investment Management LLC acquired a new stake in Tabula Rasa HealthCare during the third quarter worth approximately $4,296,000. Emerald Advisers Inc. PA acquired a new stake in Tabula Rasa HealthCare during the third quarter worth approximately $3,989,000. Finally, Wells Fargo & Company MN acquired a new stake in Tabula Rasa HealthCare during the third quarter worth approximately $3,738,000. Institutional investors own 23.79% of the company’s stock.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

5 Day Chart for NASDAQ:TRHC

Get a free copy of the Zacks research report on Tabula Rasa HealthCare (TRHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

What are top analysts saying about Tabula Rasa HealthCare Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Tabula Rasa HealthCare Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit